CN101774969B - 硫酸伊伐布雷定及其i型结晶的制备方法 - Google Patents
硫酸伊伐布雷定及其i型结晶的制备方法 Download PDFInfo
- Publication number
- CN101774969B CN101774969B CN200910003042XA CN200910003042A CN101774969B CN 101774969 B CN101774969 B CN 101774969B CN 200910003042X A CN200910003042X A CN 200910003042XA CN 200910003042 A CN200910003042 A CN 200910003042A CN 101774969 B CN101774969 B CN 101774969B
- Authority
- CN
- China
- Prior art keywords
- crystallization
- ivabradine sulfate
- ivabradine
- type
- sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Description
Claims (10)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910003042XA CN101774969B (zh) | 2009-01-13 | 2009-01-13 | 硫酸伊伐布雷定及其i型结晶的制备方法 |
PCT/CN2009/074689 WO2010081342A1 (zh) | 2009-01-13 | 2009-10-29 | 硫酸伊伐布雷定及其i型结晶的制备方法 |
JP2011544769A JP5640017B2 (ja) | 2009-01-13 | 2009-10-29 | イバブラジン硫酸塩及びそのi型結晶の製造方法 |
US13/144,287 US8541405B2 (en) | 2009-01-13 | 2009-10-29 | Methods for the preparation of Ivabradine sulfate and form I crystal thereof |
EP09838129.6A EP2388248B1 (en) | 2009-01-13 | 2009-10-29 | Methods for the preparation of ivabradine sulfate and form i crystal thereof |
HK10111668.6A HK1145676A1 (en) | 2009-01-13 | 2010-12-15 | Method for the preparation of ivabradine sulfate and form i thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910003042XA CN101774969B (zh) | 2009-01-13 | 2009-01-13 | 硫酸伊伐布雷定及其i型结晶的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101774969A CN101774969A (zh) | 2010-07-14 |
CN101774969B true CN101774969B (zh) | 2012-07-04 |
Family
ID=42339422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910003042XA Active CN101774969B (zh) | 2009-01-13 | 2009-01-13 | 硫酸伊伐布雷定及其i型结晶的制备方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8541405B2 (zh) |
EP (1) | EP2388248B1 (zh) |
JP (1) | JP5640017B2 (zh) |
CN (1) | CN101774969B (zh) |
HK (1) | HK1145676A1 (zh) |
WO (1) | WO2010081342A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2528026T3 (es) | 2007-05-30 | 2015-02-03 | Ind-Swift Laboratories Limited | Sales de oxalato de ivabridina cristalino y polimorfos de los mismos |
EP2726462B1 (en) | 2011-08-02 | 2017-03-22 | Sandoz AG | Acetone solvate of ivabradine hydrochloride |
CZ305096B6 (cs) | 2013-10-02 | 2015-04-29 | Zentiva, K.S. | Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice |
CZ305436B6 (cs) | 2014-07-10 | 2015-09-16 | Zentiva, K.S. | Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice |
GB201621771D0 (en) * | 2016-12-20 | 2017-02-01 | Biogena (A P I) Ltd | New salts of compounds and uses thereof |
IT202000025312A1 (it) | 2020-10-26 | 2022-04-26 | Cambrex Profarmaco Milano S R L | Processi per la preparazione di polimorfi di ivabradina hcl |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737495A (en) * | 1985-06-01 | 1988-04-12 | Dr. Karl Tomae, Gmbh | (2H)-3-benzazepin-2-ones, their pharmaceutical compositions and their pharmaceutical uses |
CN1827600A (zh) * | 2005-02-28 | 2006-09-06 | 瑟维尔实验室 | 盐酸伊伐布雷定的β-晶形、其制备方法和含有它的药物组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3519735A1 (de) * | 1985-06-01 | 1986-12-04 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
JP2005066615A (ja) | 2003-08-21 | 2005-03-17 | Daihen Corp | 消耗電極ガスシールドアーク溶接の溶接開始時アーク長制御方法 |
FR2882554B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882555B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882556B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2891827B1 (fr) | 2005-10-11 | 2007-12-28 | Servier Lab | Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2891826B1 (fr) | 2005-10-11 | 2007-12-28 | Servier Lab | Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
ES2528026T3 (es) * | 2007-05-30 | 2015-02-03 | Ind-Swift Laboratories Limited | Sales de oxalato de ivabridina cristalino y polimorfos de los mismos |
FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2933975B1 (fr) * | 2008-07-17 | 2011-02-18 | Servier Lab | Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
FR2935381B1 (fr) * | 2008-08-29 | 2010-12-17 | Servier Lab | Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine |
-
2009
- 2009-01-13 CN CN200910003042XA patent/CN101774969B/zh active Active
- 2009-10-29 EP EP09838129.6A patent/EP2388248B1/en not_active Not-in-force
- 2009-10-29 US US13/144,287 patent/US8541405B2/en active Active
- 2009-10-29 JP JP2011544769A patent/JP5640017B2/ja not_active Expired - Fee Related
- 2009-10-29 WO PCT/CN2009/074689 patent/WO2010081342A1/zh active Application Filing
-
2010
- 2010-12-15 HK HK10111668.6A patent/HK1145676A1/xx not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737495A (en) * | 1985-06-01 | 1988-04-12 | Dr. Karl Tomae, Gmbh | (2H)-3-benzazepin-2-ones, their pharmaceutical compositions and their pharmaceutical uses |
CN1827600A (zh) * | 2005-02-28 | 2006-09-06 | 瑟维尔实验室 | 盐酸伊伐布雷定的β-晶形、其制备方法和含有它的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
EP2388248A4 (en) | 2012-06-13 |
EP2388248B1 (en) | 2015-07-29 |
CN101774969A (zh) | 2010-07-14 |
WO2010081342A1 (zh) | 2010-07-22 |
JP2012515141A (ja) | 2012-07-05 |
JP5640017B2 (ja) | 2014-12-10 |
US20110275614A1 (en) | 2011-11-10 |
US8541405B2 (en) | 2013-09-24 |
EP2388248A1 (en) | 2011-11-23 |
HK1145676A1 (en) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101774969B (zh) | 硫酸伊伐布雷定及其i型结晶的制备方法 | |
CN102985416B (zh) | 制备凝血酶特异性抑制剂的方法 | |
EP2170844B1 (en) | Novel polymorphs of erlotinib hydrochloride and method of preparation | |
US9309226B2 (en) | Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereof | |
CN103930414B (zh) | 7-{(3s,4s)-3-[(环丙基氨基)甲基]-4-氟吡咯烷-1-基}-6-氟-1-(2-氟乙基)-8-甲氧基-4-氧-1,4-二氢喹啉-3-羧酸晶体 | |
US7989494B2 (en) | Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide | |
JP2008510754A (ja) | レルカニジピンの塩 | |
WO2011054917A1 (en) | Process for the production of polymorph form i of agomelatine | |
EP3490973B1 (en) | Polymorphic forms of belinostat and processes for preparation thereof | |
EP2883877A1 (en) | Crystalline forms of prasugrel salts | |
US6040479A (en) | Racemic separation of ketamine | |
WO2011104723A2 (en) | Acid addition salts of ivabradine and preparation thereof | |
RU2167153C2 (ru) | Способ получения моногидрата ропивакаина гидрохлорида | |
EP3508478B1 (en) | Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefor and application thereof | |
CN101353325B (zh) | 稳定型盐酸伊伐布雷定结晶及其制备方法 | |
WO2016058564A1 (en) | Salts of bedaquiline | |
CN102336701A (zh) | 硫酸卡维地洛的结晶、其制备方法及其在医药上的应用 | |
WO2014079356A1 (zh) | 恩曲他滨水杨酸盐及其晶型、制备方法和用途 | |
TWI499587B (zh) | 硫酸伊伐佈雷定及其i型結晶的製備方法 | |
CN107778232B (zh) | 一种四氢异喹啉的盐衍生物及其晶体的制备方法和应用 | |
HU187600B (en) | Process for preparing 2-methyl-9,10-didehydro-ergolines | |
CN103373952B (zh) | 硫酸卡维地洛的新晶型 | |
EP3368506B1 (en) | Process for the preparation of enclomiphene citrate having needle shaped crystal habit. | |
KR20230062916A (ko) | 피마살탄 무수물 a형 결정다형 및 그 제조방법 | |
CN110668994A (zh) | 左旋卡维地洛盐晶型、其制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1145676 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1145676 Country of ref document: HK |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170704 Address after: 222047 Kunlun Road, Lianyungang economic and Technological Development Zone, Jiangsu, No. 7 Co-patentee after: Jiangsu Sheng Di Pharmaceutical Co., Ltd. Patentee after: Hengrui Medicine Co., Ltd., Jiangsu Prov. Address before: 222002 No. 145, Renmin East Road, Sinpo District, Jiangsu, Lianyungang Patentee before: Hengrui Medicine Co., Ltd., Jiangsu Prov. |